A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.

• Main Authors: Nicholas O Opoku (Author), Felix Doe (Author), Bettina Dubben (Author), Nicole Fetcho (Author), Kerstin Fischer (Author), Peter U Fischer (Author), Shelter Gordor (Author), Charles W Goss (Author), Michael E Gyasi (Author), Achim Hoerauf (Author), Augustine R Hong (Author), Eric Kanza (Author), Christopher L King (Author), Ruth Laryea (Author), Daphne Lew (Author), Mahmood A Seidu (Author), Gary J Weil (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Onchocerciasis ("river blindness") has been targeted for elimination. New treatments that kill or permanently sterilize female worms could accelerate this process. Prior studies have shown that triple drug treatment with ivermectin plus diethylcarbamazine and...